STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Nov. 30, 2024	Nov. 30, 2023	Nov. 30, 2024	Nov. 30, 2023
Operating expenses
Research and development	$ 301,183	$ 218,069	$ 804,447	$ 614,240
General and administrative	51,056	214,946	288,962	358,284
Total operating expenses	352,239	433,015	1,093,409	972,524
Operating loss	(352,239)	(433,015)	(1,093,409)	(972,524)
Loss before provision for income tax	(352,239)	(433,015)	(1,093,409)	(972,524)
Provision for income tax	0	0
Net loss	$ (352,239)	$ (433,015)	$ (1,093,409)	$ (972,524)
Earnings per share information:
Loss per common share Basic	$ 0	$ 0	$ (0.01)	$ (0.01)
Loss per common share Diluted	$ 0	$ 0	$ (0.01)	$ (0.01)
Weighted average common shares outstanding:
Weighted average number of common shares outstanding Basic	131,448,444	131,448,444	131,448,444	131,448,444
Weighted average number of common shares outstanding Diluted	131,448,444	131,448,444	131,448,444	131,448,444